Showing 131-140 of 10129 results for "".
Look to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.'Clean Beauty' in Dermatology: A Scoping Review
https://practicaldermatology.com/issues/july-2025/clean-beauty/36492/The emergence of “clean beauty” as a consumer label has become a notable marketing trend, developed in the absence of standardized regulatory definitions, and it has been associated with shifts in consumer behaviors on a global scale.What’s Really in a “Collagen” Supplement?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/whats-really-in-a-collagen-supplement/23579/Concerns about lack of transparency of sourcing, potential for allergic reactions, and reports of contamination have been associated with collagen supplements.The Benefits of Private Practice: A Q&A with Joel Schlessinger, MD, FAAD
https://practicaldermatology.com/issues/september-2025/the-benefits-of-private-practice-a-qa-with-joel-schlessinger-md-faad/37630/While selling to and working for private equity–backed platforms may have its perks, many long-time private practitioners warn that the advantages of private practice are often not fully appreciated until it is too late. Practical Dermatology Chief Cosmetic Surgery Editor Emeritus Joel Schlessinger,Comorbidities in Hidradenitis Suppurativa
https://practicaldermatology.com/issues/march-2025/comorbidities-in-hidradenitis-suppurativa/33164/Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterized by inflamed abscesses, nodules forming tunnels that can lead to scarring in intertriginous areas.Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Current Sunscreen Controversies Impeding Patient Compliance
https://practicaldermatology.com/topics/practice-management/current-sunscreen-controversies-impeding-patient-compliance/20992/Patient concerns should not prevent the physician from advising adequate sunscreen use.Melanoma in Skin of Color: More to Learn
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-in-skin-of-color-more-to-learn/23486/With evidence showing that cumulative UV exposure is not strongly correlated with melanoma risk in patients with skin of color, dermatologists must re-consider their messaging.Mineral Sunscreens with Iron Oxides are Underused for Dyschromia in Skin of Color
https://practicaldermatology.com/topics/skin-of-color/mineral-sunscreens-with-iron-oxides-are-underused-for-dyschromia-in-skin-of-color/23697/A local survey highlights the opportunity for dermatologists to counsel and educate skin of color patients on the use of tinted mineral sunscreens for bothersome dyschromia.Seborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/seborrheic-dermatitis-update-a-review-of-the-etiology-and-treatment-of-seborrheic-dermatitis/24003/Seborrheic dermatitis (SD) is an inflammatory skin condition that often involves flaky, erythematous patches on sebum-rich areas of the body such as the face and scalp.1 At least 50 million Americans have a form of seborrheic dermatitis on the scalp, more commonly known as dandruff. SD presents in a